Feed XRAY
XR

DENTSPLY SIRONA

XRAY · NASDAQ

$9.38 -7.27% (-$0.73)
1M -14.96%
Market Cap $2.10B
P/E Ratio -
Div. Yield 3.05%
ROE 39.81%

Bulios Fair Price

$9.96

6.2% upside

Current Price

$9.38

Undervalued Fair Value Overvalued

According to Bulios Fair Price, XRAY is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
63 /100
Fair
P/S 0.58x
P/B 1.56x
P/FCF 14.71x
Growth
5 /100
Declining
FCF growth 34.38%
Book val. growth 29.42%
Rev. growth 2.10%
Profitability
44 /100
Moderate
Net margin 14.99%
Op. margin 11.69%
FCF margin 3.93%
Quality
42 /100
Average
ROE 39.81%
ROA 10.49%
Asset turnover 0.70x
Debt
21 /100
High
Current ratio 1.63x
Int. coverage -2.81x
Net debt/EBITDA 12.05x
Stability
56 /100
Moderate
Rev. volatility 2.83%
EPS volatility 394.68%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about XRAY
Online

About the company

DENTSPLY SIRONA Inc. is a U.S.-based multinational company and one of the largest manufacturers of dental products and equipment worldwide. The company specializes in producing a wide range of dental care products, including tools for orthodontics, endodontics, implantology, dental laboratories, and imaging technologies. DENTSPLY SIRONA focuses on providing innovative and high-quality solutions for dental professionals, contributing to better oral hygiene and dental care for patients around the globe.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Daniel T. Scavilla

Employees

14,000

Headquarters

Charlotte

Upcoming events

05 NOV

Earnings

Upcoming earnings report

48d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.